Tatiana Erazo, Scientific Research Lead at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn:
“At American Association for Cancer Research (ASCR), and I couldn’t be more excited.
I’ll be presenting our work on blood-based biomarkers for neuroendocrine prostate cancer, an aggressive disease whose heterogeneous biology demands better tools than a single biopsy can offer.
Join me at: Proteomics: Biomarker Discovery and Signaling Networks · April 22, 9:00 a.m. – 12:00 p.m.
Let’s connect.”
Other articles about Tatiana Erazo on OncoDaily.